405 related articles for article (PubMed ID: 25410968)
21. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
22. Preparation of sildenafil citrate microcapsules and in vitro/in vivo evaluation of taste masking efficiency.
Yi EJ; Kim JY; Rhee YS; Kim SH; Lee HJ; Park CW; Park ES
Int J Pharm; 2014 May; 466(1-2):286-95. PubMed ID: 24607218
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
24. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.
Petrovick GF; Kleinebudde P; Breitkreutz J
Eur J Pharm Biopharm; 2018 Jan; 122():137-145. PubMed ID: 29106946
[TBL] [Abstract][Full Text] [Related]
25. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets.
Douroumis DD; Gryczke A; Schminke S
AAPS PharmSciTech; 2011 Mar; 12(1):141-51. PubMed ID: 21181510
[TBL] [Abstract][Full Text] [Related]
26. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
Sheshala R; Khan N; Darwis Y
Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
[TBL] [Abstract][Full Text] [Related]
27. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
[TBL] [Abstract][Full Text] [Related]
28. Application of a quality-by-design approach for utilizing sodium stearyl fumarate as a taste-masking agent in dextromethorphan hydrobromide orally disintegrating tablets.
Mahrous GM; Ibrahim MA; Mostafa HF; Elzayat EM
Pharm Dev Technol; 2019 Jul; 24(6):711-719. PubMed ID: 30714850
[TBL] [Abstract][Full Text] [Related]
29. Taste Masking of Griseofulvin and Caffeine Anhydrous Using Kleptose Linecaps DE17 by Hot Melt Extrusion.
Juluri A; Popescu C; Zhou L; Murthy RN; Gowda VK; Chetan Kumar P; Pimparade MB; Repka MA; Murthy SN
AAPS PharmSciTech; 2016 Feb; 17(1):99-105. PubMed ID: 26288942
[TBL] [Abstract][Full Text] [Related]
30. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets.
Khan S; Kataria P; Nakhat P; Yeole P
AAPS PharmSciTech; 2007 Jun; 8(2):Article 46. PubMed ID: 17622121
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
Drašković M; Medarević D; Aleksić I; Parojčić J
Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
[TBL] [Abstract][Full Text] [Related]
32. Formulation and evaluation of bitter taste-masked orally disintegrating tablets of high memantine hydrochloride loaded granules coated with polymer via layering technique.
Kadota K; Terada H; Fujimoto A; Nogami S; Uchiyama H; Tozuka Y
Int J Pharm; 2021 Jul; 604():120725. PubMed ID: 34029663
[TBL] [Abstract][Full Text] [Related]
33. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
[TBL] [Abstract][Full Text] [Related]
34. Formulation and in vitro evaluation of ketoprofen fast-dissolving tablets.
Comoglu T; Inal O; Yaacoub HB
Pharm Dev Technol; 2016 Dec; 21(8):901-908. PubMed ID: 25798913
[TBL] [Abstract][Full Text] [Related]
35. Preparation and evaluation of orally rapidly disintegrating tablets containing taste-masked particles using one-step dry-coated tablets technology.
Kondo K; Niwa T; Ozeki Y; Ando M; Danjo K
Chem Pharm Bull (Tokyo); 2011; 59(10):1214-20. PubMed ID: 21963629
[TBL] [Abstract][Full Text] [Related]
36. An in-vivo and in-vitro taste masking evaluation of bitter melt-extruded drugs.
Maniruzzaman M; Bonnefille M; Aranyos A; Snowden MJ; Douroumis D
J Pharm Pharmacol; 2014 Feb; 66(2):323-37. PubMed ID: 24180412
[TBL] [Abstract][Full Text] [Related]
37. Rapidly disintegrating tablets containing taste masked metoclopramide hydrochloride prepared by extrusion-precipitation method.
Randale SA; Dabhi CS; Tekade AR; Belgamwar VS; Gattani SG; Surana SJ
Chem Pharm Bull (Tokyo); 2010 Apr; 58(4):443-8. PubMed ID: 20410620
[TBL] [Abstract][Full Text] [Related]
38. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
[TBL] [Abstract][Full Text] [Related]
39. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants.
Sheshala R; Khan N; Chitneni M; Darwis Y
Arch Pharm Res; 2011 Nov; 34(11):1945-56. PubMed ID: 22139694
[TBL] [Abstract][Full Text] [Related]
40. An in-vitro-in-vivo taste assessment of bitter drug: comparative electronic tongues study.
Maniruzzaman M; Douroumis D
J Pharm Pharmacol; 2015 Jan; 67(1):43-55. PubMed ID: 25182780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
